期刊文献+

靶向Akt1的siRNA抑制卵巢癌细胞系生长的体外研究 被引量:2

Growth inhibition on human ovarian carcinoma cells by small interfering RNA targeting Akt1
下载PDF
导出
摘要 目的:探讨靶向Akt1的siRNA抑制人卵巢癌细胞系SKOV3的Akt1表达后,对细胞增殖和侵袭的抑制作用。方法:将Akt1特异性siRNA转染人卵巢癌细胞系SKOV3,Real-time PCR检测Akt1 mRNA表达,Western blot和免疫荧光技术检测Akt1、Akt2、PI3Kp85α和Ki-67的蛋白表达;MTT法和Annexin V标记评价其对细胞增殖活性和凋亡的影响,流式细胞法分析细胞周期变化,Transwell法分析对侵袭能力的影响。结果:转染Akt1 siRNA后可明显下调Akt1 mRNA表达;Akt1、PI3Kp85α、Akt2和Ki-67蛋白的表达水平均明显降低(P<0.01);卵巢癌细胞增殖活性明显降低,细胞周期出现G0/G1阻滞,并诱发细胞凋亡,细胞侵袭能力减弱(P<0.01)。结论:靶向Akt1的siRNA可显著抑制卵巢癌细胞Akt1的表达,进而抑制肿瘤细胞的生长和侵袭,有望成为卵巢癌基因治疗的分子靶点。 Objective:To investigate growth inhibition effect on ovarian carcinoma cell line SKOV3 by siRNA targeting Akt1.Methods:RNAi technology was used to observe its inhibitory effect on the growth of human ovarian carcinoma SKOV3 cells.The expressions of Akt1 mRNA were detected by real-time PCR after transfection.The expressions of Akt1,Akt2,PI3Kp85α,Ki-67 were also studied by Western blot and immunofluorescence staining after transfection.MTT methods and annexin V staining were used to evaluate cell proliferation and apoptosis.Flow cytometry was used for cell cycle analysis.Tumor invasion was examined by Transwell analysis.Results:SKOV3 mRNA expression was obviously knocked down after transfection with siRNA.Compared to control and nonsense siRNA transfected cells,SKOV3 cells transfected with siRNA targeting Akt1 showed lowering proliferation activity,while the expressions of PI3Kp85α,Akt1,Akt2,Ki-67 were downregulated.The transfected cells had higher apotosis rate and most cells arresting in the G0/G1 phase.The migration and invasive ability was attenuated.Conclusion:SiRNA targeting Akt1 down regulate expressions of Akt1,inhibit ovarian carcinoma cell proliferation and migration,arrest cell cycle and induce apoptosis in vitro.Consequently,Akt1 can be the promising candidate genes for gene therapy of ovarian cancer.
出处 《现代妇产科进展》 CSCD 2012年第5期345-349,共5页 Progress in Obstetrics and Gynecology
关键词 AKT1 RNAI 卵巢肿瘤 增殖 Akt1 siRNA Ovarian neoplasms Proliferation
  • 引文网络
  • 相关文献

参考文献10

  • 1Manning BD, Cantley LC. AKT/PKB signaling: navigating downstream [ J ]. Cell, 2007,129 ( 7 ) : 1261 - 1274.
  • 2Geering B, Cutillas PR, Nock G, et al. Class IA phos- phoinositide 3-kinases are obligate p85-pl10 heterodim- ers [ J ]. Proc Natl Acad Sci USA, 2007,104 (19) : 7809- 7814.
  • 3Osaki M, Oshimura M, Ito H. PI3K/Akt Pathway : Its func- tions and alterations in human cancer [ J ]. Apoptosis, 2004,9(6) :667-676.
  • 4Jin CY, Moon Do, Lee JD, et al. Sulforaphane sensitizes tumor necrosis factor-related apoptosis-inducing ligand- mediated apoptosis through down regulation of ERK and Akt in lung adenocarcinoma A549 ceils [ J ]. Carcinogene- sis ,2007,28 (5) : 1058-1066.
  • 5Noske A, Kaszubiak A, Weichert W, et al. Specific inhibi- tion of AKT2 by RNA interference results in reduction of ovarian cancer cell proliferation: increased expression of AKT in advanced ovarian cancer [ J ]. Cancer Lett, 2007, 246(1-2) : 190-200.
  • 6Huang Q, Lan F,Zheng Z, et al. AKT2 suppresses GAPDH mediated-apoptosis in ovarian cancer cells via phosphoryl- ating GAPDH at threonine 237 and decreasing its nuclear translocation [ J ]. Biol Chem, 2011,286 (49) :42211- 42220.
  • 7Chen J, Somanath PR, Razorenova O, et al. Aktl regulates pathological angiogenesis, Vascular maturation and permea- bility in vivo[ J ]. Nat Med,2005,11 ( 11 ) : 1188-1196.
  • 8Somanath PR, Kandel ES, Hay N, et al. AKTl signaling regulates integrin activation, matrix recognition and fi- bronectin assembly [ J ]. Biol Chem, 2007, 282 ( 31 ) : 22964 -22976.
  • 9Tu ML, Wang HQ, Chen LJ, et al. Involvement of Aktl/ protein kinase B in tumor conditioned medium-induced endothelial cell migration and smwival in vitro[ J]. Cancer Res Clin Oncol,2009,135 ( 11 ) : 1543-1550.
  • 10朱颖军,薛凤霞,高企贤.卵巢癌组织芯片中PI3K p85α,AKT1及Ki-67表达的研究[J].天津医药,2008,36(8):578-580. 被引量:4

二级参考文献8

  • 1李咏梅,刘晓红,曹晓哲,王力,朱明华.着丝粒蛋白A在原发性肝癌中的表达[J].中华病理学杂志,2007,36(3):175-178. 被引量:12
  • 2Geering B, Cutillas PR, Nock G,et aL Class IA phosphoinositide 3-kinases are obligate p85--p 110 heterodimers[J]. Proc Natl Acad Sci USA, 2007, 104(19):7809-7814.
  • 3Gershtein ES, Scherbakov AM, Shatskaya VA, et al. Phosphatidylinositol 3 -kinase/AKT signalling pathway components in human breast cancer, clinicopathological correlations [J]. Anticancer Res, 2007, 27 (4A):1777-1782.
  • 4Solit DB, Basso AD, Olshen AB, et al. Inhibition of heat shock protein 90 function down-regulates Akt kinase and sensitizes tumors to taxol[J]. Cancer Res, 2003,63(9):2139-2144.
  • 5Shekar SC, Wu H, Fu Z, et al. Mechanism of constitutive phosphoinositide 3-kinase activation by oncogenic mutants of the p85 regulatory subunit[J]. J Biol Chem, 2005,280(30):27850-27855.
  • 6Shukla S, Maclennan GT, Hartman DJ,et al. Activation of PI3K-Akt signaling pathway promotes prostate cancer cellinvasion[J]. Int J Cancer,2007, 121(7):1424-1432.
  • 7Murakami D, Tsujitani S, Osaki T,et al. Expression of phosphorylated Akt (pAkt) in gastric carcinoma predicts prognosis and efficacy of chemotherapy[J]. Gastric Cancer,2007,10(1):45-51.
  • 8Kumar A, Carrera AC. New functions for PI3K in the control of cell division [J]. Cell Cyclc,2007,6(14):1696-1698.

共引文献3

同被引文献26

引证文献2

二级引证文献8

;
使用帮助 返回顶部